Gastrointestinal Devices Market Seen Reaching $17.46 Billion by 2030

The gastrointestinal devices market is forecast to grow from $11.7 billion in 2025 to $12.69 billion in 2026, with North America holding the largest share. The Business Research Company says demand is being driven by rising digestive disease rates, more outpatient procedures and wider use of AI-assisted diagnostics.

Why it matters: - The gastrointestinal devices market is tied to rising demand for diagnosis and treatment of digestive diseases. - Faster growth in outpatient procedures, advanced endoscopy and AI-assisted diagnostics is reshaping hospital and clinic purchasing. - The market outlook points to expanding opportunities for device makers, endoscopy centers and healthcare providers focused on patient safety and efficiency.

What happened: - The Business Research Company released a market outlook on gastrointestinal devices on August 7, 2026. - The report puts the market at $11.7 billion in 2025 and $12.69 billion in 2026. - The report projects the market will reach $17.46 billion by 2030. - North America held the largest share of the market in 2025. - Asia-Pacific ranked second. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample of the report is available. - The full report is also available.

The details: - Gastrointestinal devices are designed to diagnose and treat conditions affecting the digestive system and gastrointestinal tract. - The market grew on the back of rising gastrointestinal disorders, expansion of gastroenterology departments in hospitals, advances in endoscopic imaging, more screening programs and wider availability of advanced GI devices. - The 2026 forecast implies a 8.5% CAGR from 2025 to 2026. - The longer-term forecast implies an 8.3% CAGR through 2030. - Future growth is expected to come from AI-assisted gastrointestinal diagnostics, investment in advanced endoscopy centers, more outpatient GI procedures and demand for single-use devices. - The report also highlights a push for improved patient safety and operational efficiency. - Key trends include more sophisticated GI endoscopic techniques, rising use of capsule endoscopy systems, more minimally invasive GI treatments, wider therapeutic endoscopy applications and stronger early disease detection tools. - In July 2023, Crohn’s and Colitis Canada projected that inflammatory bowel disease cases in Canada will rise to 470,000 by 2035 from about 322,600 in 2023.

Between the lines: - The market outlook suggests gastrointestinal care is shifting toward earlier detection, less invasive procedures and more automation. - The emphasis on single-use devices points to continued concern about infection control and workflow efficiency. - The regional split shows North America remains the commercial center, while Asia-Pacific continues to gain scale. - The report’s added analytics, including TAM analysis, company scoring matrix graphics and forecasting dashboards, indicate a stronger focus on planning and competitive positioning.

What's next: - Device makers are likely to lean into AI-enabled diagnostics, capsule endoscopy and therapeutic endoscopy platforms. - Hospitals and outpatient centers are expected to keep investing in tools that shorten procedures and improve safety. - The company says its 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and Excel-based forecasting dashboards. - More investor and supplier attention is likely to shift toward market hotspots and future trend analysis. - For more information, the company can be reached through the contact details included in the report announcement.

The bottom line: - Gastrointestinal devices remain a growth market, with demand supported by rising disease prevalence and a steady shift toward less invasive, tech-enabled care.